Medical ProductsCompany
Novartis AG - TOBRADEX & NATACYN Ownership
Who owns Novartis AG - TOBRADEX & NATACYN?
Novartis AG - TOBRADEX & NATACYN is owned by Eyevance Pharmaceuticals and Hayfin Capital Management. It was acquired on October 16, 2019.
Novartis AG - TOBRADEX & NATACYN Business Overview
Where is Novartis AG - TOBRADEX & NATACYN headquartered?
Novartis AG - TOBRADEX & NATACYN is headquartered in Basel, Switzerland.
What sector is Novartis AG - TOBRADEX & NATACYN in?
Novartis AG - TOBRADEX & NATACYN is a medical products company.
Medical Products M&A Summary in 2019
Out of 60 sectors in the Mergr database, medical products ranked 13 in number of deals in 2019. The largest medical products acquisition in 2019 was Acelity - which was acquired by 3M Company for $6.7B.
Join Mergr to view all 204 acquisitions of medical products companies in 2019, including 28 acquisitions by private equity firms, and 176 by strategics.